Abstract: A new family of ring-annulated inositols with ™locked∫ conformations has been designed to deliver a range of these biologically important entities in ™unnatural conformations∫ while retaining their ™natural configurations∫. The simple ™tool∫ of trans ring fusion has been used to ™lock∫ the conformation of the annulated inositols. Short, simple syntheses of a range of these novel cyclitols have been achieved from readily available aromatic precursors such as tetralin and indane. Along the way, annulated C 2 -symmetric cyclohexadiene-trans-diol (trans-CHD) derivatives have been prepared for the first time and serve as the pivotal building blocks for generating the oxy-functionalization pattern of inositols. The presence of chemo-differentiated hydroxyl groups in our novel inositols is expected to facilitate the installation of phosphate diversity to harness the biological potential of these entities.
Introduction
Inositols 1 occupy a preeminent position among biologically important entities known as cyclitols and constitute the only group of cyclohexanes substituted at each carbon atom for which all the possible (nine) diastereomers, five natural (myo, scyllo, d-chiro, l-chiro, and neo) and four synthetic (cis, epi, allo, and muco), are known. [1] The biological functions of derivatives of inositol are wide-ranging and diverse and include intercellular communication, phosphate storage and transfer, anti-cancer and involvement in covalent anchoring of proteins to membranes. [1a±c, 2] However, it is the pivotal role of inositol phosphate derivatives such as d-myo-inositol-1,4,5-triphosphate [Ins(1,4,5)P 3 ] and d-myo-inositol-1,3,4,5-tetrakisphosphate [Ins(1,3,4,5)P 4 ] as second messengers in intercellular signal transduction events through binding to specific receptors and mobilizing Ca 2 ions from intracellular stores that has generated contemporary interest in their chemistry and biology. [1, 2] The increased cytosolic Ca 2 concentration initiates a number of cell-type specific responses.
[1b, 2] Thus, intervention and selective manipulation of physiological processes triggered by inositol polyphosphates has stimulated the search for new and designer analogues for unraveling the complex biological mechanisms and development of new pharmaceuticals.
The quest for new synthetic analogues of inositols, though extensive, [3, 4] has largely centered on ring modification and sidearm and phosphate variation and studies with these structural variants continue to provide insights into structure ± activity relationships. Here, we introduce a new family of ring-annulated bicyclic inositols 2 as novel entities with several unique attributes. The trans-fused bicyclic inositols 2, unlike 1, are rigid and can be locked in high-energy conformations (see below) which are unattainable in 1.
[5]
For example, while the most abundant myo-inositol exists in the stable conformation 3 with five equatorial and one axial (5e/1a) hydroxyl group, the 1,6-annulated bicyclic myoinositol 4 would be locked in the five axial and one equatorial (5a/1e) conformation. Secondly, the presence of two chemodifferentiated tertiary hydroxyl groups in 2 is expected to facilitate the generation of functional group diversity and phosphate variation, an essential but complicated feature of inositol chemistry. [1] It should be noted that selective phosphorylation of inositols is a cumbersome, multistep protocol which requires extensive protection ± deprotection maneuvers. Lastly, a hydrophobic appendage in the form of an alicyclic ring in 2 could profoundly modulate the cell membrane permeability and receptor recognition parameters of the inositol moiety. Interestingly, the ring annulation maneuver on inositols, which leads to 2, can be expected to alter their reactivity and biological profile and has not been attempted before.
[3h] More importantly, the annulated inositols are destined to be locked in ™unnatural conformations∫ while retaining their ™natural configurations∫. In this paper, we describe a simple and versatile approach to several cyclohexa-and cyclopenta-annulated inositols 2 from readily available aromatic precursors such as tetralin and indane. While the syntheses reported here are of racemic compounds, our overall strategy is amenable to chiral induction at several stages along the way. In our general approach to 2, annulated C 2 -symmetric cyclohexadiene-trans-diol (trans-CHD) derivatives 5 and 6 were recognized as the pivotal building blocks and access to them from readily available precursors was first devised. [6, 7] For the synthesis of cyclohexa-annulated trans-CHD 5, 1,4-dihydrotetralin (7) obtained from tetralin was subjected to regioselective epoxidation to give 8 followed by acid-catalyzed ring opening to a trans diol [8] and acetylation to furnish the trans diacetate 9 (Scheme 1). Allylic bromination of 9 and DBU (1,8-diazabicyclo[5. 4 .0]undec-7-ene)-mediated dehydrobromination delivered the desired C 2 -symmetric cyclohexadiene-trans-diol diacetate 5. [9] In a similar manner, cyclopenta-annulated cyclohexadiene-trans-diol derivative 6 was prepared from 1,4-dihydroindane (10) via trans-diol 11 (Scheme 2). [10] The allylic bromination-dehydrobromination sequence, successful in the case of 9, led only to intractable products when implemented on 11 or its diacetate derivative. After some trials, a convenient route to the C 2 -symmetric trans-CHD derivative 6 from 11 was established through addition of bromine and acetylation to 12 and double dehydrobromination in the presence of DBU. [9] The C 2 -symmetric bicyclic trans-CHD diacetates 5 and 6 served as the key starting materials for accessing the new family of inositols. The main theme in our approach was to generate the network of oxygen functionalities on the diene moiety in a stereoselective manner and with the minimum number of steps. Mono-epoxidation of 5 was stereoselective and furnished a readily separable mixture of diastereomeric epoxides 13 and 14 (9:1) (Scheme 1).
Acid-catalyzed ring opening of the major epoxide 13 furnished bicyclic diols 15 (3:1) and 16, which are annulated conduritol F and B derivatives, respectively (Scheme 3). [11, 12] The stereostructure of the acetate migration product 15, though indicated through careful scrutiny of the spectral data, was secured through X-ray crystallography studies. The origin of 15 from epoxide 13 can be traced to an intramolecular neighboring acetate-mediated opening of the epoxide ring followed by an S N 2' displacement by the distal acetate group as shown in Scheme 4. It is this eventful participation of both the acetate groups of 13 in the epoxide ring opening that generates the interesting cis-1,4-diol stereo- chemistry observed in 15 (Scheme 4). [13] The major product 15 from epoxide 13 was then subjected to stereospecific OsO 4 -mediated dihydroxylation to furnish the inositol derivative 17 (Scheme 3). The stereochemical outcome of the dihydroxylation of 15 to give 17 was predictable and expected both on steric considerations and Kishi×s rule [14] for the OsO 4 -mediated dihydroxylation of allylic alcohols. Base hydrolysis of 17 led to the 2,3-cyclohexa-annulated chiro-inositol 18. [15] The most stable conformation of chiro-inositol determined by X-ray crystallography is 4e/2a as shown in Scheme 5. [16] In contrast, the X-ray crystal structure of 2,3-cyclohexa-annulated chiro-inositol 18 exhibited a 4a/2e conformation and is displayed for comparison in Scheme 5. Attention was now turned to the minor diol 16 obtained from the cleavage of epoxide 13. Acetate hydrolysis of 16 led to the tetrol 19, which is an annulated conduritol B derivative (Scheme 3). [11] Catalytic OsO 4 -mediated dihydroxylation of 19 was smooth and stereospecific and furnished the cyclohexaannulated myo-inositol 4. An X-ray crystal structure of 4 indicated that as per our design strategy it indeed had a 5a/1e ground state conformation in contrast with 5e/1a for myoinositol 3.
[17] Once again, dihydroxylation of 19 occurred from the face opposite to the secondary allylic hydroxyl group. [14] In an alternate sequence, bicyclic diene diacetate 5 was subjected to exhaustive dihydroxylation with catalytic OsO 4 to stereospecifically furnish the hexaoxygenated products 20 (2:1) and 21, with the latter arising through 1,4-acetate migration (Scheme 6). Base hydrolysis of both 20 and 21 furnished 3,4-cyclohexa-annulated chiro-inositol 22. [15] The stereostructure of 22 was evident from the C 2 symmetry present and this annulated chiroinositol was locked in the 4a/2e conformation. It is noteworthy that starting from the same trans-CHD diacetate 5, two inositols (18 and 22) with the chiro-configuration and 4a/2e conformation can be crafted by a tactic that is formally equivalent to altering the site of annulation (2,3-and 3,4-, respectively) [15] on chiro-inositol. The elaboration of the cyclohexadiene-trans-diol derivative 6 to diverse cyclopenta-annulated inositols followed the protocols successfully implemented on 5 (see above). Epoxidation of 6 was less stereoselective (cf. 5) and furnished a readily separable mixture (2:1) of epoxides 23 and 24 (Scheme 2). Acid-catalyzed ring opening of the major epoxide 23 furnished diols 25 and 26 in a 3:1 ratio (Scheme 7). The stereostructures of conduritol F 25 and conduritol B 26 derivatives [11] were secured through X-ray crystal structure determination. The major product was once again derived through complex acetate migration analogous to that observed for 13 (Scheme 4). [13] Acetate hydrolysis in 25 furnished the annulated conduritol F derivative 27, and further catalytic OsO 4 -mediated dihydroxylation led stereospecifically to the 2,3-cyclopenta-annulated [15] chiro-inositol 28. Inositol 28 was firmly locked in 4a/2e conformation. Similarly, the minor epoxide cleavage product 26 was hydrolyzed to give conduritol B derivative 29, and further dihydroxylation furnished the cyclopenta-annulated myo-inositol 30 which was locked in the 5a/1e ground state conformation (Scheme 7). [17] On acid cleavage the remaining minor epoxide 24 obtained from 6 furnished a single product 31 in which both the acetate groups had migrated (Scheme 8). Hydrolysis of 31 led to the conduritol E derivative 32, and further OsO 4 -mediated dihydroxylation furnished the annulated allo-inositol 33. The stereostructure of 33 was secured through single-crystal X-ray structure determination and had a locked 3a/3e conformation. Lastly, the annulated trans-CHD diol 6 was subjected to mono-dihydroxylation to stereospecifically give the diol 34 with concomitant 1,4-acetate migration (Scheme 9). The stereostructure of 34 was again secured through X-ray crystal structure determination. Acetate hydrolysis in 34 provided a conduritol F derivative 35, and a second OsO 4 -mediated dihydroxylation led to the 3,4-cyclopenta-annulated chiroinositol 36, [15] which adopts a 4a/2e conformation.
Conclusion
We have delineated short and efficient routes to ringannulated C 2 -symmetric trans-CHD diols 5 and 6 and harnessed them to craft a range of novel bicyclic inositols. Our design of these unusual entities employs the annulation stratagem for generating new ™unnatural∫ conformations and structural diversity while retaining the ™natural∫ configurations of the inositols. The availability of such bicyclic inositols with differentiated hydroxyl groups with new spatial orientations augurs well for further phosphate variations and biological evaluation.
Experimental Section
General methods: Melting points were recorded on a B¸chi B-540 apparatus and are uncorrected. Infrared spectra were recorded on JASCO FTIR 410. Proton ( 1 H NMR) and carbon magnetic resonance ( 13 C NMR) spectra were generally recorded on a JEOL JNM-LA 300 spectrometer. Mass spectra measurements were carried out on a JEOL JMS DX 303 spectrometer. Elemental analyses were carried out on a Carlo Erba Element Analyzer 1106. Analytical thin-layer chromatography (TLC) was performed on (10 Â 5 cm) glass plates coated (250 mm) with Acme silica gel G or GF 254 (containing 13 % calcium sulfate as binder). Visualization of the spots on TLC plates was achieved either by exposure to iodine vapor or UV light or by spraying sulfuric acid and heating the plates at 120 8C. Column chromatography was performed by using Acme silica gel (100 ± 200 mesh) or neutral alumina. All solvents were freshly distilled over CaH 2 or Na/benzophenone as appropriate.
(4aR *,8aR *)-1,2,3,4,4a,5,8,8a-Octahydro-4a,8a-naphthalenediol (9): Epoxide 8 (3 g, 0.02 mol) [8] was treated with 10 % acetic acid (10 mL), and the resulting biphasic reaction mixture was stirred vigorously at room temperature. Upon complete consumption of the starting material (monitored by TLC), the acid was neutralized by careful addition of solid NaHCO 3 , and the resulting diol was extracted with ethyl acetate (3 Â 100 mL). The combined organic extracts were washed with saturated aqueous NaHCO 3 (2 Â 50 mL), brine (1 Â 50 mL), dried over anhydrous Na 2 SO 4 , and concentrated under reduced pressure to furnish the trans diol (3 g, 90 %). The diol was dissolved in acetic anhydride (10 mL) and a catalytic amount of BF 3 ¥ Et 2 O (100 mL) was added at 0 8C. The resulting dark brown solution was stirred for 2 h under N 2 atmosphere. The reaction mixture was poured into ice-cold water (10 mL) and extracted with CH 2 Cl 2 (3 Â 100 mL). The combined organic extracts were washed with saturated aqueous NaHCO 3 (2 Â 50 mL), brine (20 mL), dried over anhydrous Na 2-SO 4 , and concentrated under reduced pressure to furnish crystalline trans diacetate 9 (4.7 g), which was recrystallized from hexane/dichloromethane to give colorless needle-like crystals of 9 (4.54 g, 88 % (4aR *,8aR *)-8a-(Acetyloxy)-1,2,3,4,4a,8a-hexahydro-4-naphthalenyl acetate (5): N-Bromosuccinimide (706 mg, 3.97 mmol) and a catalytic amount of 2,2'-azabisisobutyronitrile (AIBN) (10 mg) were added to a solution of the trans-diacetate 9 (1 g, 3.97 mmol) in dry CCl 4 (10 mL), and the resulting reaction mixture was heated at reflux for 4 h under N 2 . After the completion of the reaction, floating succinimide was filtered off and the filtrate was poured into ice-cold water (15 mL). The organic layer was separated and aqueous layer was extracted with CH 2 Cl 2 (3 Â 20 mL). The combined organic extracts were successively washed with 10 % HCl, (2 Â 10 mL), water (10 mL), brine (10 mL), dried over anhydrous Na 2 SO 4 , and concentrated under reduced pressure. The residue (1.3 g) obtained was dissolved in dry DMSO (10 mL) and DBU (0.7 mL, 4.76 mmol) was added gradually from a syringe at 5 ± 10 8C under N 2 atmosphere, during which time the reaction mixture turned from pale yellow to dark brown. The reaction mixture was stirred at room temperature for further 2 h, before diluting with diethyl ether (20 mL) and pouring into ice-cold water (20 mL). The ether layer was separated and the aqueous layer was extracted with diethyl ether (3 Â 30 mL). The combined organic extracts were washed with 10 % HCl (2 Â 10 mL), water (10 mL), brine (10 mL), dried over anhydrous Na 2 SO 4 , and concentrated under reduced pressure to furnish the crude product (530 mg), which on chromatography over neutral alumina column (5 % ethyl acetate/hexane) gave the crystalline trans-diene 5 (516 mg, 52 % Compound 12: Pyridiniumbromide perbromide (8.22 g, 0.025 mmol) was added to a solution of the known [10] trans-diol 11 (3.6 g, 0.023 mol) in dry CH 2 Cl 2 (50 mL), and the reaction mixture was stirred at 0 8C under N 2 atmosphere. After consumption of the starting material (monitored by TLC), the reaction mixture was diluted with CH 2 Cl 2 (50 mL) and poured into ice-cold water (100 mL). The organic layer was separated and the aqueous layer was extracted with CH 2 Cl 2 (3 Â 30 mL). The combined organic extracts were washed successively with saturated aqueous Na 2 S 2 O 5 solution (2 Â 20 mL), water (20 mL), brine (20 mL), and dried over anhydrous Na 2 SO 4 . Concentration of the solvent and purification of the resultant solid residue by silica gel chromatography afforded the dibromodiol (4. . The dibromodiol was dissolved in acetic anhydride (10 mL) and BF 3 ¥ Et 2 O (100 mL) was added at 0 8C and stirred at the same temperature for 1 h under N 2 . On complete consumption of the starting material (monitored by TLC), the reaction mixture was quenched by the careful addition of ice-cold water (50 mL) and diluted with CH 2 Cl 2 (30 mL). The aqueous layer was extracted with CH 2 Cl 2 (3 Â 30 mL) and the combined organic extracts were washed carefully with saturated aqueous NaHCO 3 (2 Â 20 mL), brine (20 mL), and dried over anhydrous Na 2 SO 4 . The residue obtained after concentration at reduced pressure was purified by silica gel chromatography to furnish the dibromodiacetate 12 (5. (3aR *,7aR *)-2,3,3a,7a-Tetrahydro-1H-3a,7a-indenediol (6): Dibromodiacetate 12 (1 g, 2.51 mmol) was dissolved in dry DMSO (5 mL) and DBU (0.75 mL, 5.02 mmol) was added dropwise at 5 ± 10 8C from a syringe under N 2 atmosphere, during which time the reaction turned dark brown. The reaction mixture was stirred at room temperature for further 2 h, before diluting with diethyl ether (30 mL) and pouring into ice-cold water (10 mL). The organic layer was separated and the aqueous layer was extracted with diethyl ether (3 Â 50 mL). The combined organic extracts were washed with 10 % HCl (2 Â 20 mL), water (20 mL), brine (15 mL), dried over anhydrous Na 2 SO 4 , and concentrated under reduced pressure. The resultant solid residue was purified by chromatography over neutral alumina (5 % ethyl acetate/hexane) to furnish crystalline trans-diene 6 (319 mg, 54 %). M.p. 139. Compounds 13 and 14: mCPBA (70 %, 493 mg, 2 mmol) was added at 0 8C to a solution of 5 (500 mg, 2 mmol) in dry CH 2 Cl 2 (10 mL), and the reaction mixture was stirred at room temperature for 5 h before quenching with 10 % Na 2 SO 3 (5 mL). The organic layer was separated and the aqueous layer was extracted with CH 2 Cl 2 (3 Â 30 mL). The combined organic layer was washed with saturated aqueous NaHCO 3 (2 Â 10 mL), brine (10 mL), and dried over anhydrous Na 2 SO 4 . The solvent was removed under reduced pressure to give a solid residue, which by TLC examination was found to be a mixture of two compounds. The residue was subjected to silica gel column chromatography (5 % ethyl acetate/hexane) to furnish epoxides 13 (295 mg, 66 %) and 14 (31 mg, 7 %), along with recovered starting material 5 (80 mg), in an overall yield of 73 %. 
Compounds 15 and 16:
A solution of epoxide 13 (250 mg, 0.94 mmol) in THF (5 mL) was treated with 10 % AcOH (2 mL), and the resulting mixture was stirred at 50 8C for 16 h. Upon completion of the reaction (monitored by TLC), the mixture was cooled and neutralized by the addition of solid NaHCO 3 , followed by extraction with ethyl acetate (3 Â 30 mL). The combined organic extracts were washed with saturated aqueous NaHCO 3 (2 Â 10 mL), brine (10 mL), dried over anhydrous Na 2 SO 4 , and concentrated under reduced pressure to give a solid. Purification of the residue by column chromatography over silica gel (30 % ethyl acetate/hexane) gave 15 (160 mg, 60 %) and 16 (53 mg, 20 %) as colorless crystalline solids in 80 % overall yield. Crystal data for compound 15: Structure was solved by direct methods (SIR92). Refinement was by full-matrix least-squares procedures on F 2 by using SHELXL-97. Crystal system: rhombohedral-hexagonal, space group: R3c, cell parameters: a 27.761 (2) Compound 17: OsO 4 (2 mg, 1 mol %) and 50 % aqueous N-methylmorpholine N-oxide (NMMO) (130 mL, 0.56 mmol) were added to a solution of diol 15 (155 mg, 0.545 mmol) in acetone/water (4:1, 5 mL) at 0 8C, and the resulting pale yellow reaction mixture was stirred at room temperature for 2 h, before quenching with solid NaHSO 3 . The resulting mixture was diluted with ethyl acetate (10 mL), filtered through Celite, and the filtrate was concentrated under reduced pressure. The residue was subjected to column chromatography over silica gel (80 % ethyl acetate/hexane) to afford the tetrol 17 (152 mg, 88 %). IR (KBr): n Ä 3391, 1727 cm Annulated myo-inositol 4: The annulated inositol 4 (18 mg, 80 %) was obtained from the olefin 19 (20 mg, 0.1 mmol) by dihydroxylation following the procedure described above for the conversion of 15 to 17 but using OsO 4 (1 mg, 5 mol %) and NMMO (30 mL, 0.128 mmol) in acetone/water (4:1, 1 mL) and purification by silica gel column chromatography ( Crystal data for the compound 4: Structure was solved by direct methods (SIR92). Refinement was by full-matrix least-squares procedures on F 2 by using SHELXL-97. Crystal system: triclinic, space group: P1 ≈ , cell parameters: a 6.113(1), b 7.612(1), c 11.667(2) ä, a 102.326(4) 
data wR2 0.0963, GOF 1.100, restrained GOF 1.100 for all data. An ORTEP drawing of compound 4 with 50 % ellipsoidal probability level is shown in Figure 3 . Compound 23 and 24: Mono-epoxidation of 6 was carried out by following a procedure similar to that described for 5 by treating the diene (1.2 g, 5.08 mmol) with mCPBA (70 %, 1.25 g, 5.08 mmol) in dry CH 2 Cl 2 (10 mL) at 0 8C, followed by chromatography over silica gel (elution with 10 % ethyl acetate/hexane) to furnish mono-epoxides 23 (537 mg, 42 %) and 24 (230 mg, 18 %). Compound Crystal data for the compound 25: Structure was solved by direct methods (SIR92). Refinement was by full-matrix least-squares procedures on Annulated chiro-inositol 28: The tetrol 27 (128 mg, 0.688 mmol) was dihydroxylated by following a procedure similar to that described for 17 but using OsO 4 (2 mg, 1 mol %) and NMMO (175 mL, 0.75 mmol) in acetone/ water (4:1, 3 mL), followed by chromatography over silica gel (10 Crystal data for the compound 34: Structure was solved by direct methods (SIR92). Refinement was by full-matrix least-squares procedures on F 2 by using SHELXL-97. Crystal system: monoclinic, space group: P2 1 /n, cell parameters: a 7.027 (1) Compound 35: Diol diacetate 34 (100 mg, 0.370 mmol) was hydrolyzed with K 2 CO 3 (102 mg, 0.74 mmol) in methanol (2 mL) followed by purification by chromatography over silica gel (10 % Compound 36: Tetrol 35 (45 mg, 0.242 mmol) was subjected to a procedure similar to that detailed for the conversion of 19 to 4 but with OsO 4 (2 mg, 2 mol %) and NMMO (60 mL, 0.25 mmol) in acetone/water (4:1, 2 mL), followed by purification by chromatography over silica gel (10 % 
